Molecular Biology of Human Respiratory Syncytial Virus

Perspectives in Medical Virology

Volumn 14, Issue , 2006, Pages 1-42

  Melero, José A ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750897417     PISSN: 01687069     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0168-7069(06)14001-X     Document Type: Review

References (200)

1. Ahmadian G., Chambers P., and Easton A.J. Detection and characterization of proteins encoded by the second ORF of the M2 gene of pneumovirus. J Gen Virol 80 (1999) 2011-2016
2. Ahmadian G., Rhandawa J.S., and Easton A.J. Expression of the ORF-2 protein of the human respiratory syncytial virus M2 gene is initiated by a ribosomal termination-dependent reinitiation mechanism. EMBO J 19 (2000) 2681-2689
3. Anderson L.J., Heirholzer J.C., Tson C., Hendry R.M., Fernie B.N., Stone Y., and McIntosh K. Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis 151 (1985) 626-633
4. Anderson K., King A.M.Q., Lerch R.A., and Wertz G.W. Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses. Virology 191 (1992) 417-430
5. Apostopoulos V., and McKenzie I.F.C. Cellular mucins: targets for immunotherapy. Crit Rev Immunol 14 (1994) 293-309
6. Arbiza J., Taylor G., López J.A., Furze J., Wyld S., Whyte P., Stott E.J., Wertz G., Sullender W., Trudel M., and Melero J.A. Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol 73 (1992) 2225-2234
7. Arnold R., König B., Werchau H., and König W. Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells. Virology 330 (2004) 384-397
8. Arumugham R.G., Seid Jr. R.C., Doyle S., Hildreth S.W., and Paradiso P.R. Fatty acid acylation of the fusion glycoprotein of human respiratory syncytial virus. J Biol Chem 264 (1989) 10339-10342
9. Asenjo A., Rodriguez L., and Villanueva N. Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: a possible role for serine 54. J Gen Virol 86 (2005) 1109-1120
10. Asenjo A., and Villanueva N. Regulated but not constitutive human respiratory syncytial virus (HRSV) P protein phosphorylation is essential for oligomerization. FEBS Lett 467 (2000) 279-284
11. Bächi T., and Howe C. Morphogenesis and ultrastructure of respiratory syncytial virus. J Virol 12 (1973) 1173-1180
12. Bangham C.R.M., and McMichael A.J. Specific human cytotoxic T cells recognise B cell lines persistently infected with respiratory syncytial virus. Proc Natl Acad Sci USA 83 (1986) 9183-9187
13. Barik S. Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s). J Virol 66 (1992) 6813-6818
14. Barik S., McLean Y., and Dupuy LC. Phosphorylation of Ser232 directly regulates the transcriptional activity of the P protein of human respiratory syncytial virus: phosphorylation of Ser237 may play an accessory role. Virology 213 (1995) 405-412
15. Barr J., Chambers P., Pringle C.R., and Easton A.J. Sequence of the major nucleocapsid protein gene of pneumonia virus of mice: sequence comparisons suggest structural homology between nucleocapsid proteins of pneumovirus, paramyxoviruses, rhabdoviruses and filoviruses. J Gen Virol 72 (1991) 677-685
16. Beeler J.A., and van Wyke Coelingh K. Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. J Virol 63 (1989) 2941-2950
17. Bermingham A., and Collins P.L. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci USA 96 (1999) 11259-11264
18. Bhella D., Ralph A., Murphy L.B., and Yeo R.P. Significant differences in nucleocapsid morphology within the Paramyxoviridae. J Gen Virol 83 (2002) 1831-1839
19. Bossert B., Marozi S., and Conzelmann K.-K. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 77 (2003) 8661-8668
20. Buchholz U.J., Finke S., and Conzelman K.-K. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73 (1999) 251-259
21. Bukreyev A., Whitehead S.S., Murphy B.R., and Collins P.L. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J Virol 71 (1997) 8973-8982
22. Burke E., Dupuy L., Wall C., and Barik S. Role of cellular actin in the gene expression and morphogenesis o human respiratory syncytial virus. Virology 252 (1998) 137-148
23. Burke E., Mahoney N., Almo S.C., and Barik S. Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA. J Virol 74 (2000) 669-675
24. Calder L.J., González-Reyes L., García-Barreno B., Wharton S.A., Skehel J.J., Wiley D.C., and Melero J.A. Electron microscopy of the human respiratory syncytial virus fusion protein and complexes that it forms with monoclonal antibodies. Virology 271 (2000) 122-131
25. Caravokyri C., Zajac A.J., and Pringle C.R. Assignment of mutant tsN19 (complementation group E) of respiratory syncytial virus to the P protein gene. J Gen Virol 73 (1992) 865-873
26. Cartee T.L., Megaw A.G., Oomens A.G.P., and Wertz G.W. Identification of a single amino acid change in the human respiratory syncytial virus L protein that affects transcriptional termination. J Virol 77 (2003) 7352-7360
27. Cartee T.L., and Wertz G.W. Respiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infection. J Virol 75 (2001) 12188-12197
28. Castagné N., Barbier A., Bernard J., Rezaei H., Huet J.-C., Henry C., Da Costa B., and Eléouët J.-F. Biochemical characterization of the respiratory syncytial virus P-P and P-N protein complexes and localization of the P protein oligomerization domain. J Gen Virol 85 (2004) 1643-1653
29. Chambers P., Pringle C.R., and Easton A.J. Sequence analysis of the gene encoding the fusion glycoprotein of pneumonia virus of mice suggests possible conserved secondary structure elements in paramyxovirus fusion glycoproteins. J Gen Virol 73 (1992) 1717-1724
30. Chanock R.M., Roizman B., and Myers M. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent. I. Isolation, properties and characterization. Am J Hyg 66 (1957) 281-290
31. Chen L., Gorman J.J., McKimm-Breschkin J., Lawrence L.J., Tulloch P.A., Smith B.J., Colman P.M., and Lawrence M.C. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure 9 (2001) 255-266
32. Cheng X., Park H.-J., Zhou H., and Jing H. Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication. J Virol 79 (2005) 13943-13952
33. Chizhmakov I.V., Geraghty F.M., Ogden D.C., Hayhurst A., Antoniou M., and Hay A.J. Selective proton permeability and pH regulation of the influenza virus M2 channel expressed in mouse erythroleukaemia cells. J Physiol 494 (1996) 329-336
34. Cianci C., Langley D.R., Dischino D.D., Sun Y., Yu K.-L., Stanley A., Roach J., Li Z., Dalterio R., Colonno R., Meanwell N.A., and Krystal M. Targeting a binding pocket within the trimer-of-hairpins: small-molecule inhibition of viral fusion. Proc Natl Acad Sci USA 101 (2004) 15046-15051
35. Coates H.V., Alling D.W., and Chanock R.M. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization assay. Am J Epidemiol 83 (1966) 299-313
36. Collins P.L., Anderson K., Langer S.J., and Wertz G.W. Correct sequence of the major nucleocapsid protein mRNA of respiratory syncytial virus. Virology 146 (1985) 69-77
37. Collins PL, Chanock RM, Murphy BR. Respiratory syncytial virus. In: Fields Virology (Knipe DM, Howley PM, editors). 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001; pp. 1443-1485.
38. Collins P.L., Hill M.G., Camargo E., Grosfeld H., Chanock R.M., and Murphy B.R. Production of infectious human respiratory from cloned cDNA confirms an essential role for the transcription elongation factor from the 5′ proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development. Proc Natl Acad Sci USA 92 (1995) 11563-11567
39. Collins P.L., Hill M.G., Cristina J., and Grosfeld H. Transcription elongation factor of respiratory syncytial virus, a nonsegmented negative-strand RNA virus. Proc Natl Acad Sci USA 93 (1996) 81-85
40. Collins P.L., and Mottet G. Post-translational processing and oligomerization of the fusion glycoprotein of human respiratory syncytial virus. J Gen Virol 72 (1991) 3095-3101
41. Collins P.L., and Mottet G. Oligomerization and post-translational processing of glycoprotein G of human respiratory syncytial virus: altered O-glycosylation in the presence of brefeldin A. J Gen Virol 73 (1992) 849-863
42. Collins P.L., and Mottet G. Membrane orientation and oligomerization of the small hydrophobic protein of human respiratory syncytial virus. J Gen Virol 74 (1993) 1445-1450
43. Collins P.L., and Wertz G.W. cDNA cloning and transcriptional mapping of nine polyadenylated RNAs encoded by the genome of human respiratory syncytial virus. Proc Natl Acad Sci USA 80 (1983) 3208-3212
44. Collins P.L., and Wertz G.W. The envelope-associated 22k protein of human respiratory syncytial virus: nucleotide sequence of the mRNA and a related polytranscript. J Virol 54 (1985) 65-71
45. Cowton V.M., and Fearns R. Evidence that the respiratory syncytial virus polymerase is recruited to nucleotides 1 to 11 at the 3′ end of the nucleocapsid and can scan to access internal signals. J Virol 79 (2005) 11311-11322
46. Cristina J., López J.A., Albo C., García-Barreno B., García J., Melero J.A., and Portela A. Analysis of genetic variability in human respiratory syncytial virus by the RNase A mismatch cleavage method: subtype divergence and heterogeneity. Virology 174 (1990) 126-134
47. Cuesta I., Geng X., Asenjo A., and Villanueva N. Structural phosphoprotein M2-1 of the human respiratory syncytial virus is an RNA binding protein. J Virol 74 (2000) 9858-9867
48. Curran J., and Kolakofsky D. Replication of paramyxoviruses. Adv Virus Res 54 (1999) 403-422
49. Dhiman N., Jacobson R.M., and Poland G.A. Measles virus receptors: SLAM and CD46. Rev Med Virol 14 (2004) 217-229
50. Dickens L.E., Collins P.L., and Wertz G.W. Transcriptional mapping of human respiratory syncytial virus. J Virol 52 (1984) 364-369
51. Doreleijers J.F., Langedijk J.P.M., Hard K., Boelens R., Rullmann J.A.C., Schaaper W.M., van Oirschot J.T., and Kaptein R. Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus. Biochemistry 35 (1996) 14684-14688
52. Douglas J.L., Panis M.L., Ho E., Lin K.Y., Krawczyk S.H., Grant D.M., Cai R., Swaminathan S., and Cihlar T. Inhibition of respiratory syncytial virus fusion by the small molecule VP-14637 via specific interactions with F protein. J Virol 77 (2003) 5054-5064
53. 215 and is without effect. J Virol 73 (1999) 8384-8392
54. Escribano-Romero E., Rawling J., García-Barreno B., and Melero J.A. The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans. J Virol 78 (2004) 3524-3532
55. Fearns R., and Collins P.L. Model for polymerase access to the overlapped L gene of respiratory syncytial virus. J Virol 73 (1999) 388-397
56. Fearns R., Peeples M.E., and Collins P.L. Increased expression of the N protein of respiratory syncytial virus stimulates minigenome replication but does not alter the balance between the synthesis of mRNA and antigenome. Virology 236 (1997) 188-201
57. Fearns R., Peeples M.E., and Collins P.L. Mapping the transcription and replication promoters of respiratory syncytial virus. J Virol 76 (2002) 1663-1672
58. Feldman S.A., Hendry R.M., and Beeler J.A. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 73 (1999) 6610-6617
59. Fernie B.C., Ford E.C., and Gerin J.L. The development of Balb/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface. Proc Soc Exp Biol Med 167 (1981) 83-86
60. Ferron F., Longhi S., Henrissat B., and Canard B. Viral RNA-polymerases -a predicted 2′-O-ribose methyltransferase domain shared by all Mononegavirales. Trends Biochem Sci 27 (2002) 222-224
61. Follet E.A., Pringle C.R., and Pennington T.H. Virus development in enucleated cells: echovirus, poliovirus, pseudorabies virus, reovirus, respiratory syncytial virus and Semliki Forest virus. J Gen Virol 26 (1975) 183-196
62. García J., García-Barreno B., and Melero J.A. Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that co-express the nucleoprotein, the phosphoprotein and the 22k proteins. Virology 195 (1993) 243-247
63. García-Barreno B., Delgado T., and Melero J.A. Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions. J Virol 70 (1996) 801-808
64. García-Barreno B., Jorcano J.L., Aukenbauer T., López-Galíndez C., and Melero J.A. Participation of cytoskeletal intermediate filaments in the infectious cycle of human respiratory syncytial virus (RSV). Virus Res 9 (1988) 307-322
65. García-Barreno B., Palomo C., Peñas C., Delgado T., Perez-Breña P., and Melero J.A. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J Virol 63 (1989) 925-932
66. García-Barreno B., Steel J., Payá M., Martínez-Sobrido L., Delgado T., Yeo R.P., and Melero J.A. Epitope mapping of human respiratory syncytial virus 22k transcription antitermination factor: role of N-terminal sequences in protein holding. J Virol 86 (2005) 1103-1107
67. García-Beato R., Martínez I., Francí C., Real F.X., García-Barreno B., and Melero J.A. Host cell effect upon glycosylation and antigenicity of human respiratory syncytial virus G glycoprotein. Virology 221 (1996) 301-309
68. García-Beato R., and Melero J.A. The C-terminal third of human respiratory syncytial virus attachment (G) protein is partially resistant to protease digestion and is glycosylated in a cell-type-specific manner. J Gen Virol 81 (2000) 919-927
69. Ghyldial R., Baulch-Brwon C., Mills J., and Meanger J. The matrix protein of human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch Virol 148 (2003) 1419-1429
70. Ghyldial R., Li D., Peroulis I., Shields B., Bardin P.G., Teng M.N., Collins P.L., Meanger J., and Mills J. Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J Gen Virol 86 (2005) 1879-1884
71. Ghyldial R., Mills J., Murray M., Vardaxis N., and Meanger J. Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol 83 (2002) 753-757
72. González-Reyes L., Ruiz-Argüello M.B., García-Barreno B., Calder L., López J.A., Albar J.P., Skehel J.J., Wiley D.C., and Melero J.A. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Nat Acad Sci USA 98 (2001) 9859-9864
73. Gower TL, Pastey MK, Peeples ME, Collins PL, McCurdy LH, Hart TK, Guth A, Hohnson TR, Graham BS. RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology. J Virol 2005; 79: 5326-5336.
74. Groothuis J.R., and Nishida H. Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab). Pediatr Int 44 (2002) 235-241
75. Grosfeld H., Hill M.G., and Collins P.L. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P and L proteins: transcription also occurs under these conditions but requires superinfection for efficient synthesis of full-length mRNA. J Virol 69 (1995) 5677-5686
76. Guerrero-Plata A., Ortega E., and Gomez B. Persistence of respiratory syncytial virus in macrophages alters phagocytosis and pro-inflammatory cytokine production. Viral Immunol 14 (2001) 19-30
77. Hallak L.K., Collins P.L., Knudson W., and Peeples M.E. Iduronic acid-containing glycosaminoglycans on target cells are required for efficient respiratory syncytial virus infection. Virology 271 (2000) 264-275
78. Hallak L.K., Spillmann D., Collins P.L., and Peeples M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74 (2000) 10508-10513
79. Hansen J.E., Lund O., Tolstrup N., Gooley A.A., Williams K.L., and Brunak S. NetOglyc: prediction of mucin type O-glycosylation sites based on sequence content and surface accesibility. Glycoconj J 15 (1998) 115-130
80. Hardy R.W., Harmon S.B., and Wertz G.W. Diverse gene junctions of respiratory syncytial virus modulate the efficiency of transcription termination and respond differently to M2-mediated antitermination. J Virol 73 (1999) 170-176
81. 1 motif of the respiratory syncytial virus M2-1 protein is essential for proper function. J Virol 74 (2000) 5880-5885
82. Harmon S.B., Megaw A.G., and Wertz G.W. RNA sequences involved in transcription termination of respiratory syncytial virus. J Virol 75 (2001) 36-44
83. Harmon S.B., and Wertz G.W. Transcription termination modulated by nucleotides outside the characterized gene end sequence of respiratory syncytial virus. Virology 300 (2002) 304-315
84. Hegele R.G., Hayashi S., Bramley A.M., and How J.C. Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. Chest 105 (1994) 1848-1854
85. Henderson G., Murray J., and Yeo R.P. Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoprotein. Virology 300 (2002) 244-254
86. Hendricks D.A., Baradaran K., McIntosh K., and Patterson J.L. Appearance of a soluble form of the G protein of respiratory syncytial virus in fluids of infected cells. J Gen Virol 68 (1987) 1705-1714
87. Hendricks D.A., McIntosh K., and Patterson J.L. Further characterisation of the soluble form of the G glycoprotein of respiratory syncytial virus. J Virol 62 (1988) 2228-2233
88. Hoffman S.J., Laham F.R., and Polack F.P. Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microb Infect 6 (2004) 767-772
89. Huang Y.T., Collins P.L., and Wertz G.W. Characterization of the 10 proteins of human respiratory syncytial virus: identification of a fourth envelope-associated protein. Virus Res 2 (1985) 157-173
90. Jentoft N. Why are proteins O-glycosylated?. Trends Biochem Sci 15 (1990) 291-294
91. Jin H., Clarke D., Zhou H.Z., Cheng X., Coelingh K., Bryant M., and Li S. Recombinant human respiratory syncytial virus (RSV) from cDNA and construction of subgroup A and B chimeric RSV. Virology 251 (1998) 206-214
92. Johnson P.R., and Collins P.L. The fusion glycoprotein of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness. J Gen Virol 69 (1988) 2623-2628
93. Johnson P.R., and Collins P.L. Sequence comparison of the phosphoprotein mRNAs of antigenic subgroups A and B of human respiratory syncytial virus identifies a highly divergent domain in the predicted protein. J Gen Virol 71 (1990) 481-485
94. Johnson P.R., Spriggs M.K., Olmsted R.A., and Collins P.L. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins. Proc Natl Acad Sci USA 84 (1987) 5625-5629
95. Juhasz K., Murphy B.R., and Collins P.L. The major attenuating mutation of respiratory syncytial virus vaccine candidate cpts530/1009 specify temperature-sensitive defects in transcription and replication and a non-temperature-sensitive alteration in mRNA termination. J Virol 73 (1999) 5176-5180
96. Karlin D., Ferron F., Canard B., and Longhi S. Structural disorder and modular organization in Paramyxovirinae N and P. J Gen Virol 84 (2003) 3239-3252
97. Karron R.A., Buonagurio D.A., Georgiu A.F., Whitehead S.S., Adamus J.E., Clements-Mann M.L., Harris D.O., Randolph V.-B., Udem S.A., Murphy B.R., and Sidhu M.S. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci USA 94 (1997) 13961-13966
98. Khattar S.K., Yunus A.S., and Samal S.K. Mapping the domains on the phosphoprotein of bovine respiratory syncytial virus required for N-P and P-L interactions using a minigenome system. J Gen Virol 82 (2001) 775-779
99. Krusat T., and Streckert H.J. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch Virol 142 (1997) 1247-1254
100. Kuo L., Fearns R., and Collins P.L. Analysis of the gene start and gene end signals of human respiratory syncytial virus: quasi-templated initiation at position 1 of the encoded mRNA. J Virol 71 (1997) 4944-4953
101. Kuo L., Grosfeld H., Cristina J., Hill M.G., and Collins P.L. Effects of mutations in the gene-start and gene-end sequence motifs on transcription of monocistronic and dicistronic minigenomes of respiratory syncytial virus. J Virol 70 (1996) 6892-6901
102. Lamb R.A. Paramyxovirus fusion: a hypothesis for changes. Virology 197 (1993) 1-11
103. Lamb RA, Kolakofsky D. Paramyxoviridae: the viruses and their replication. In: Fields Virology (Knipe, DM, Howley PM, editors). 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001; pp.1443-1485.
104. Lamb R.A., Paterson R.G., and Jardetzky T.S. Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology 344 (2006) 30-37
105. Lambert D.M., Barney S., Lambert A.L., Guthrie K., Medinas R., Davis D.E., Bucy T., Erickson J., Merutka G., and Petteway Jr. S.R. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci USA 93 (1996) 2186-2191
106. Langedijk J.P.M., de Groot B.L., Berendsen J.C., and van Oirschot J.T. Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor. Virology 243 (1998) 293-302
107. Langedijk J.P.M., Schaaper W.M.M., Meloen R.H., and van Oirschot J.T. Proposed three-dimensional model for the attachment protein G of respiratory syncytial virus. J Gen Virol 77 (1996) 1249-1257
108. Lawless-Delmenico M.K., Sista P., Sen R., Moore N.C., Antczak J.B., White J.M., Greene R.J., Leanza K.C., Matthews T.J., and Lambert D.M. Heptad-repeat regions of respiratory syncytial virus F1 protein form a six-membered coiled-coil complex. Biochemistry 39 (2000) 11684-11695
109. LeVine A.M., Elliott J., Whitsett J.A., Srikiatkhachorn A., Crouch E., DeSilva N., and Korfhagen T. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol 31 (2004) 193-199
110. LeVine A.M., Gwozdz J., Stark J., Bruno M., Whitsett J., and Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 103 (1999) 1015-1021
111. Levine S., Klaiber-Franco R., and Paradiso P.R. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J Gen Virol 68 (1987) 2521-2524
112. Liuzzi M., Mason S.W., Cartier M., Lawetz C., McCollum R.S., Dansereau N., Bolger G., Lapeyre N., Gaudette Y., Lagace L., Massariol M.J., Do F., Whitehead P., Lamarre L., Scouten E., Bordeleau J., Landry S., Rancourt J., Fazal G., and Simoneau B. Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylation by viral RNA-dependent RNA polymerase. J Virol 79 (2005) 13105-13115
113. Llorente M.T., García-Barreno B., Calero M., Camafeita E., López J.A., Longhi S., Ferrón F., Varela P.F., and Melero J.A. Structural analysis of the human respiratory syncytial virus phosphoprotein: characterization of an α-helical domain involved in oligomerization. J Gen Virol 87 (2006) 159-169
114. Lo M.S., Brazas R.M., and Holtzman M.J. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 79 (2005) 9315-9319
115. López J.A., Bustos R., Örvell C., Berois M., Arbiza J., García-Barreno B., and Melero J.A. Antigenic structure of human respiratory syncytial virus fusion glycoprotein. J Virol 72 (1998) 6922-6928
116. Lu B., Brazas R., Ma C.-H., Kristoff T., Cheng X., and Jin H. Identification of temperature-sensitive mutations in the phosphoprotein of respiratory syncytial virus that are likely involved in its interaction with the nucleoprotein. J Virol 76 (2002) 2871-2880
117. Markwell M.A.K., and Paulson J.C. Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants. Proc Natl Acad Sci USA 77 (1980) 5693-5697
118. Markwell M.A.K., Portner A., and Schwartz A.L. An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking the attachment protein. Proc Natl Acad Sci USA 82 (1985) 978-982
119. Martín D., Calder LJ., García-Barreno B., Skehel JJ., and Melero JA. Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity. J Gen Virol 87 (2006) 1649-1658
120. Martínez I., Bustos J., and Melero J.A. Reduced expression of surface glycoproteins in mouse fibroblasts persistently infected with human respiratory syncytial virus (HRSV). Arch Virol 146 (2001) 669-683
121. Martínez I., Dopazo J., and Melero J.A. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J Gen Virol 78 (1997) 2419-2429
122. Martínez I., and Melero J.A. Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein. J Gen Virol 79 (1998) 2215-2220
123. Martínez I., and Melero J.A. Binding of human respiratory syncytial virus to cells: implication of sulfated cell surface proteoglycans. J Gen Virol 81 (2000) 2715-2722
124. Marty A., Meanger J., Mills J., Shields B., and Ghyldial R. Association of matrix protein of respiratory syncytial virus with the host cell membrane of infected cells. Arch Virol 149 (2004) 199-210
125. Mason S.W., Aberg E., Lawetz C., DeLong R., Whitehead P., and Liuzzi M. Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1 dependent RSV minigenome activity. J Virol 77 (2003) 10670-10676
126. Mason S.W., Lawetz C., Gaudette Y., Dô F., Scouten E., Lagacé L., Simoneau B., and Liuzzi M. Polyadenylation-dependent screening assay for respiratory syncytial virus RNA transcriptase activity and identification of an inhibitor. Nucl Acids Res 32 (2004) 4758-4767
127. Matthews J.M., Young T.F., Tucker S.P., and Mackay J.P. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil. J Virol 74 (2000) 5911-5920
128. McGivern D.R., Collins P.L., and Fearns R. Identification of internal sequences in the 3′ leader region of human respiratory syncytial virus that enhance transcription and confer replication processivity. J Virol 79 (2005) 2449-2460
129. Melero J.A., García-Barreno B., Martínez I., Pringue C.R., and Cane P.A. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachement (G) protein. J Gen Virol 78 (1997) 2411-2418
130. Mink M.A.D., Stec D.S., and Collins P.L. Nucleotide sequence of the 3′ leader and 5′ trailer regions of human respiratory syncytial virus genomic RNA. Virology 185 (1991) 615-624
131. Mononegavirales. In: ICTVdB-The Universal Virus Database, version 3 (Büchen-Osmond C, editor). New York, NY, USA: ICTVdB Management, Columbia University; 2003.
132. Morris J.A., Blount R.E., and Savage R.E. Recovery of cytopathic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 92 (1956) 544-550
133. Morton C.J., Cameron R., Lawrence L.J., Lin B., Lowe M., Luttick A., Mason A., McKimm-Breschkin J., Parker M.W., Ryan J., Smout M., Sullivan J., Tucker S.P., and Young P.R. Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay. Virology 311 (2003) 275-278
134. Moudy R.M., Harmon S.B., Sullender W.M., and Wertz G.W. Variations in transcription termination signals of human respiratory syncytial virus clinical isolates affect gene expression. Virology 313 (2003) 250-260
135. Moudy R.M., Sullender W.M., and Wertz G.W. Variations in intergenic region sequences of human respiratory syncytial virus clinical isolates: analysis of effects on transcriptional regulation. Virology 327 (2004) 121-133
136. Mould J.A., Li H.C., Dudlak C.S., Lear J.D., Pekosz A., Lamb R.A., and Pinto L.H. Mechanism for proton conduction of the M(2) ion channel of influenza A virus. J Biol Chem 275 (2000) 8592-8599
137. Mufson M.A., Örvell C., Rafnar B., and Norrby E. Two distinct subtypes of human respiratory syncytial virus. J Gen Virol 66 (1985) 2111-2124
138. Murphy L.B., Loney C., Murray J., Bhella D., Ashton P., and Yeo R.P. Investigation into the amino-terminal domain of the respiratory syncytial virus nucleocapsid protein reveal elements important for nucleocapsid formation and interaction with the phosphoprotein. Virology 307 (2003) 143-153
139. Murray J., Loney C., Murphy L.B., Graham S., and Yeo R.P. Characterization of monoclonal antibodies raised against recombinant respiratory syncytial virus nucleocapsid (N) protein: Identification of a region in the carboxy terminus of N involved in the interaction with P protein. Virology 289 (2001) 252-261
140. Navarro J., Lopez-Otín C., and Villanueva N. Location of phosphorylated residues in human respiratory syncytial virus phosphoprotein. J Gen Virol 72 (1991) 1455-1459
141. Ogino T., Kobayashi M., Iwama M., and Mizumoto K. Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA. J Biol Chem 280 (2005) 4429-4435
142. Palomo C., Albar J.P., García-Barreno B., and Melero J.A. Induction of a neutralizing immune response to human respiratory syncytial virus with anti-idiotypic antibodies. J Virol 64 (1990) 4199-4206
143. Palomo C., Cane P.A., and Melero J.A. Evaluation of antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains. J Med Virol 60 (2000) 468-474
144. Palomo C., García-Barreno B., Peñas C., and Melero J.A. The G protein of human respiratory syncytial virus: significance of carbohydrate side-chains and the C-terminal end to its antigenicity. J Gen Virol 72 (1991) 669-675
145. Panuska J.R., Cirino N.M., Midulla F., Despot J.E., McFadden Jr. E.R., and Huang Y.T. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J Clin Invest 86 (1990) 113-119
146. Peeples M.E., and Collins P.L. Mutations in the 5′ trailer region of a respiratory syncytial virus minigenome which limit RNA replication to one step. J Virol 74 (2000) 146-155
147. Pérez M., García-Barreno B., Melero J.A., Carrasco L., and Guinea R. Membrane permeability changes induced in Escherichia coli by the SH protein of human respiratory syncytial virus. Virology 235 (1997) 342-351
148. Poch O., Blumberg B.M., Bougueleret L., and Torodo N. Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol 71 (1990) 1153-1162
149. Poch O., Sauvaget I., Delarue M., and Tordo N. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J 8 (1989) 3867-3874
150. Polack F.P., Irusta P.M., Hoffman S.J., Schiatti M.P., Melendi G.A., Delgado M.F., Laham F.R., Thumar B.R., Michael Hendry R.M., Melero J.A., Karron R.A., Collins P.L., Steven R., and Kleeberger S.R. The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin. Proc Natl Acad Sci USA 102 (2005) 8996-9001
151. Randhawa J.S., Marriott A.C., Pringle C.R., and Easton A.J. Rescue of synthetic minireplicons establishes the absence of NS1 and NS2 genes from avian pneumovirus. J Virol 71 (1997) 9849-9854
152. Rixon H.W.M., Brown G., Aitken J., McDonald T., Graham S., and Sugrue R.J. The small hydrophobic (SH) protein accumulates within lipid-raft structures of the Golgi complex during respiratory syncytial virus infection. J Gen Virol 85 (2004) 1153-1165
153. Rixon H.W.M., Brown G., Murray J.T., and Sugrue R.J. The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen-activated protein kinase p38-dependent tyrosine kinase activity during virus infection. J Gen Virol 86 (2005) 375-384
154. Roberts S.R., Compans R.W., and Wertz G.W. Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J Virol 69 (1995) 2667-2673
155. Roberts S.R., Lichtenstein D., Ball L.A., and Wertz G.W. The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein are synthesized from alternative initiation codons. J Virol 68 (1994) 4538-4546
156. Rodríguez L., Cuesta I., Asenjo A., and Villanueva N. Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues. J Gen Virol 85 (2004) 709-719
157. Routledge E.G., Willcocks M.M., Morgan L., Samson A.C.R., Scott R., and Toms G.L. Heterogeneity of the respiratory syncytial virus 22k protein revealed by western blotting with monoclonal antibodies. J Gen Virol 68 (1987) 1209-1215
158. Ruiz-Argüello M.B., González-Reyes L., Calder L.J., Palomo C., Martín D., Saíz M.J., García-Barreno B., Skehel J.J., and Melero J.A. Effect of proteolytic processing at two distinct sites on shape and aggregation of an anchorless fusion protein of human respiratory syncytial virus and fate of the intervening segment. Virology 298 (2002) 317-326
159. Sanchez-Seco M.P., Navarro J., Martínez R., and Villanueva N. C-terminal phosphorylation of human respiratory syncytial virus P protein occurs mainly at serine residue 232. J Gen Virol 76 (1995) 425-430
160. Schlender J., Bossert B., Buchholz U., and Conzelmann K.-K. Bovine respiratory syncytial virus non-structural proteins NS1 and NS2 cooperatirely antagonize alpha/beta interferon-induced antiviral response. J Virol 74 (2000) 8234-8242
161. Schnell M.J., Mebatsion T., and Conzelmann K.-K. Infectious rabies viruses from cloned cDNA. EMBO J 13 (1994) 4195-4203
162. Schwarze J., O'Donnell D.R., Rohwedder A., and Openshaw P.J. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am J Respir Crit Care Med 169 (2004) 801-805
163. Shields B., Mills J., Ghyldial R., Gooley P., and Meanger J. Multiple heparin binding domains of respiratory syncytial virus G mediate binding to mammalian cells. Arch Virol 148 (2003) 1987-2003
164. Skehel J.J., and Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69 (2000) 317-326
165. Slack M.S., and Easton A.J. Characterization of the interaction of the human respiratory syncytial virus phosphoprotein and nucleocapsid protein using the two-hybrid system. Virus Res 55 (1998) 167-176
166. Smith B.J., Lawrence M.C., and Colman P.M. Modelling the structure of the fusion protein from human respiratory syncytial virus. Prot Engin 15 (2002) 365-371
167. Spann K.M., Tran K.C., Chi B., Rabin R., and Collins P.L. Suppression of the induction of alpha, beta and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 78 (2004) 4363-4369
168. Spann K.M., Tran K.C., and Collins P.L. Effects of non-structural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-κB, and proinflammatory cytokines. J Virol 79 (2005) 5353-5362
169. Stec D.S., Hill M.G., and Collins P.L. Sequence analysis of the polymerase L gene of human respiratory syncytial virus and predicted phylogeny of nonsegmented negative-strand virus. Virology 183 (1991) 273-287
170. Stokes H.L., Easton A.J., and Marriott A.C. Chimeric pneumovirus nucleocapsid (N) proteins allow identification of amino acids essential for the function of the respiratory syncytial virus N protein. J Gen Virol 84 (2003) 2679-2683
171. Stone-Hulslander J., and Morrison T.G. Detection of an interaction between HN and F proteins of Newcastle disease virus. J Virol 71 (1997) 6287-6295
172. Tang R.S., Nguyen N., Cheng X., and Jin H. Requirement of cysteines and length of the human respiratory syncytial virus M2-1 protein for protein function and virus viability. J Virol 75 (2001) 11328-11335
173. Tarbouriech N., Curran J., Ruigrok R.W.H., and Burmeister W.P. Tetrameric coiled coil domain of Sendai virus phosphoprotein. Nat Struct Biol 7 (2000) 777-781
174. Taylor G., Bruce C., Barbet A.F., Wyld S.G., and Thomas L.H. DNA vaccination against respiratory syncytial virus in young calves. Vaccine 23 (2005) 1242-1250
175. Techaarpornkul S., Collins P.L., and Peeples M.E. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 294 (2002) 296-304
176. Teng M.N., and Collins P.L. Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J Virol 72 (1998) 5707-5716
177. Teng M.N., Whitehead S.S., and Collins P.L. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 289 (2001) 283-296
178. Tripp R.A., Jones L.P., Haynes L.M., Zheng H., Murphy P.M., and Anderson L.J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2 (2001) 732-738
179. Valarcher J.F., Bourhy H., Lavenu A., Bourges-Abella N., Roth M., Andreoletti O., Ave P., and Schelcher F. Persistent infection of B lymphocytes by bovine respiratory syncytial virus. Virology 291 (2001) 55-67
180. Valarcher J.F., Furze J., Wyld S., Cook R., Conzelmann K.-K., and Taylor G. Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 77 (2003) 8426-8439
181. Vidal S., and Kolakofsky D. Modified model for the switch from Sendai virus transcription to replication. J Virol 63 (1989) 1951-1958
182. Villanueva N., Hardy R., Asenjo A., Yu Q., and Wertz G.W. The bulk of the phosphorylation of human respiratory syncytial virus phosphoprotein is not essential but modulates viral RNA transcription and replication. J Gen Virol 81 (2000) 129-133
183. Walsh E.E., and Hruska J. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol 47 (1983) 171-177
184. Wertz G.W., Collins P.L., Hang Y., Gruber C., Levine S., and Ball L.A. Nucleotide sequence of the G protein of human respiratory syncytial virus reveals an unusual type of membrane protein. Proc Natl Acad Sci USA 82 (1985) 4075-4079
185. Wertz G.W., Krieger M., and Ball L.A. Structure and cell surface maturation of the attachment glycoprotein of human respiratory syncytial virus in a cell line deficient in O-glycosylation. J Virol 63 (1989) 4767-4776
186. Whitehead S.S., Bukreyev A., Teng M.N., Firestone C.Y., St Claire M., Elkins W.R., Collins P.L., and Murphy B.R. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. J Virol 73 (1999) 3438-3842
187. Wild C.T., Shugars D.C., Greenvell T.K., McDanal C.B., and Matthews T.J. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci USA 91 (1994) 9770-9774
188. Worthington M.T., Amann B.T., Nathans D., and Berg J.M. Metal binding properties and secondary structure of the zinc binding domain of Nup475. Proc Natl Acad Sci USA 93 (1996) 13754-13759
189. Wright P.F., Ikizler M.R., Gonzales R.A., Carroll K.N., Hohnson J.E., and Werkhaven J.A. Growth of respiratory syncytial virus in primary epithelial cells from the human respiratory tract. J Virol 79 (2005) 8651-8654
190. Yao Q., Hu X., and Compans R.W. Association of the parainfluenza virus fusion and hemagglutini-neuraminidase glycoproteins on cell surfaces. J Virol 71 (1997) 650-656
191. Yin H.S., Paterson R.G., Wen X., Lamb R.A., and Jardetzky T.S. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci USA 102 (2005) 9288-9293
192. Yu Q., Ardí R.W., and Wertz G.W. Functional cDNA clones of the human respiratory syncytial virus N, P and L proteins support replication of RS virus genomic RNA analogs and define minimal trans-acting requirements for RNA replication. J Virol 69 (1995) 2412-2419
193. Zambrano A. Rescate de minigenomas y análisis funcional de la glicoproteína F del virus respiratorio sincitial humano (VRSH). Ph.D. Thesis, Universidad Autónoma de Madrid; 2000.
194. Zhang Y., Luxon B.A., Casola A., Garofalo R.P., Jamaluddin M., and Brasier A.R. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 75 (2001) 9044-9058
195. Zhang L., Peeples M.E., Boucher R.C., Collins P.L., and Pickles R.J. Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliates cells, and without obvious cytopathology. J Virol 76 (2002) 5654-5666
196. Zhao X., Singh M., Malshkevich V., and Kim P.S. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci USA 97 (2000) 14172-14177
197. Zhou H., Cheng X., and Jin H. Identification of amino acids that are critical to the processivity function of respiratory syncytial virus M2-1 protein. J Virol 77 (2003) 5046-5053
198. Zimmer G., Budz L., and Herrler G. Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences. J Biol Chem 276 (2001) 1642-1650
199. Zimmer G., Rohn M., McGregor G.P., Shemann M., Conzelamann K.K., and Herrler G. Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus. J Biol Chem 278 (2003) 46854-46861
200. Zimmer G., Trotz I., and Herrler G. N-glycans of F protein differentially affect fusion activity of human respiratory syncytial virus. J Virol 75 (2001) 4744-4751